hero section gradient
15 handpicked stocks

Inflation Hedge Basket

Looking to protect your money from rising prices? This collection features companies that own real, physical assets from gold mines to global infrastructure. Professional analysts have selected these stocks specifically for their ability to maintain and potentially increase in value during inflationary periods.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and investor takeaways for the provided Inflation Hedge Basket market capitalisation data.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad market moves, reducing idiosyncratic risk.
  • Suited as a core holding within a diversified portfolio, not a short-term speculative position.
  • Expect steady long-term value growth rather than rapid, short-term outperformance; returns likely moderate and gradual.
Total Market Cap
  • NEM: $94.82B

  • PAAS: $14.95B

  • FCX: $59.31B

  • Other

About This Group of Stocks

1

Our Expert Thinking

When inflation rises, money buys less over time. These companies own tangible assets like precious metals, industrial commodities, and infrastructure that historically maintain or increase in value when currencies weaken. This makes them a strategic addition to any portfolio during uncertain economic times.

2

What You Need to Know

This collection provides defensive protection through companies with intrinsic value linked to physical goods. It blends traditional inflation hedges like gold and silver miners with businesses that own essential infrastructure, offering both potential price appreciation and stable cash flows.

3

Why These Stocks

These companies were handpicked because they control real-world assets that typically perform well during inflation. Rather than purely financial instruments, these businesses extract valuable resources, manage critical infrastructure, or own physical property - all historically effective at preserving wealth.

Why You'll Want to Watch These Stocks

🛡️

Protect Your Savings

As inflation erodes the purchasing power of your cash, these companies offer a shield through ownership of real, valuable assets that tend to rise in price along with everything else.

🌍

Global Uncertainty Plays

With ongoing economic instability and geopolitical tensions, investors worldwide are turning to tangible assets as safe havens, potentially driving demand for these stocks.

💰

Dividend Potential

Many of these companies not only preserve capital but also generate income through dividends, giving you two ways to benefit while protecting against inflation.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions